Homepage

Participants in the funding announcement for Canada’s Immuno-Engineering and Biomanufacturing Hub pose for a group photo.

$140M for UBC-led research hub to accelerate drug development and biomanufacturing

Federal investment in Canada’s Immuno-Engineering and Biomanufacturing Hub projects will bolster domestic biotech sector, readiness to respond to future health threats.